前列腺癌PI-RADS 5级病灶中11.4%活检阴性，通过多因素分析发现前列腺体积＞60cc、正常DRE、既往阴性活检、过渡区病灶及TRUS未发现可疑低回声是独立预测因素，联合应用可提升诊断准确性至AUC≥0.84，为个体化随访策略提供依据。 多参数磁共振成像（mpMRI）在前列 ...

本研究针对重复前列腺活检中PI-RADS 3病变的诊断挑战，通过回顾性分析684例患者数据，发现PI-RADS 3是阴性活检的独立预测因子（OR 0.582），而PSA密度（PSAD）在PI-RADS 4-5病变中具有显著风险分层价值（62.4% vs 33.8%），在PI-RADS 3中则差异有限（20.7% vs 16.2%）。该研究为 ...

The Prostate Imaging Reporting and Data System (PI-RADS) was mainly developed for the purposes of prostate cancer (PCa) detection. However, its widespread use suggests that it may play a role in a ...

Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial.

Temporal trends and factors associated with overuse of neoadjuvant androgen deprivation therapy in low and very low risk prostate cancer. Changes in multiparametric prostate MRI and immune subsets in ...

Upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between patients whose MRI examinations were clinically interpreted using PI-RADS Version ...